New research into multiple sclerosis has presented the possibility of a new treatment for the condition.
A study published in Nature Immunology has identified a molecule known as GM-CSF that plays a key role in autoimmune diseases such as multiple sclerosis.
The scientists, from Thomas Jefferson University, believe that finding a way to block the cell-signalling molecule could lead to new treatments which would eradicate the conditions.
Study leader Abdolmohamad Rostami said: "This is the first step towards finding a new treatment.
"If we can try to neutralize GM-CSF by different means, for example, by trying to mimic it or trying to block the receptor for GM-CSF, we can hopefully ameliorate the disease."
This follows the development a new treatment for multiple sclerosis which could delay progression of the condition, reports HealthDay News.
Oral drug laquinimod was found to reduce relapse rates in a two year study and to be safe and well tolerated by patients.